![Sean Harper](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sean Harper
Président chez
3T Biosciences, Inc.
Profil
Sean E.
Harper is Chairman at 3T Biosciences, Inc. since 2022 and Director at Jamanda Ltd. Former roles include Chief Executive Officer at Onyx Pharmaceuticals, Inc., Chairman at Dantari, Inc., President & Director at BioVex Group, Inc., Senior Director-Clinical Genomics at Merck Research Laboratories Massachusetts LLC, Director at ACELYRIN, Inc., Director at Amgen Rockville, Inc. in 2012, Co-Founding Managing Director at Westlake Biopartners LLC, and Executive Vice President-Research & Development at Amgen, Inc. from 2012 to 2018.
Education includes a doctorate from the University of California, Berkeley, conferred in 1988.
Postes actifs de Sean Harper
| Sociétés | Poste | Début |
|---|---|---|
Jamanda Ltd.
 Jamanda Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | - |
3T Biosciences, Inc.
 3T Biosciences, Inc. BiotechnologyHealth Technology Operates as an immunotherapy company that develops next-generation and transformative therapies for the treatment of solid tumors and immune-mediated diseases | Président | 25/08/2022 |
Anciens postes connus de Sean Harper
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Directeur Technique/Scientifique/R&D | - |
Dantari, Inc.
 Dantari, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in creating breakthrough medicines for the treatment of cancer and serious diseases | Président | - |
| ACELYRIN, INC. | Directeur/Membre du Conseil | - |
Westlake Biopartners LLC
 Westlake Biopartners LLC Investment ManagersFinance Westlake Biopartners invests in companies located in the United States. The firm focuses on life sciences sectors. It participates in early and later stage capital requirements. | Private Equity Investor | - |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | President | - |
Formation de Sean Harper
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
3T Biosciences, Inc.
3T Biosciences, Inc. BiotechnologyHealth Technology Operates as an immunotherapy company that develops next-generation and transformative therapies for the treatment of solid tumors and immune-mediated diseases | Health Technology |
Westlake Biopartners LLC
Westlake Biopartners LLC Investment ManagersFinance Westlake Biopartners invests in companies located in the United States. The firm focuses on life sciences sectors. It participates in early and later stage capital requirements. | Finance |
ACELYRIN, Inc.
 ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
Jamanda Ltd.
Jamanda Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Dantari, Inc.
Dantari, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in creating breakthrough medicines for the treatment of cancer and serious diseases | Health Technology |
